Utility values associated with diabetic retinopathy in Chennai, India

Ophthalmic Epidemiology

Volumn 22, Issue 1, 2015, Pages 20-27

  Polack, Sarah ^a   Alavi, Yasmene ^a   Reddi, Sudhir Rachapalle ^b   Kulothungan, Vaitheeswaran ^b   Kuper, Hannah ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b VISION RESEARCH FOUNDATION   (India)

Author keywords

Diabetic retinopathy; India; Quality of life; Utility values

Indexed keywords

ADULT; ARTICLE; BLINDNESS; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; DIABETIC RETINOPATHY; DISEASE SEVERITY; ECONOMIC EVALUATION; FEMALE; HUMAN; INDIA; MACULAR EDEMA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; UTILITY VALUE; VISION; VISUAL ACUITY; CLASSIFICATION; COST BENEFIT ANALYSIS; HEALTH SERVICES RESEARCH; HEALTH STATUS INDICATOR; PSYCHOLOGY; QUALITY ADJUSTED LIFE YEAR; SICKNESS IMPACT PROFILE;

COST-BENEFIT ANALYSIS; DIABETIC RETINOPATHY; FEMALE; HEALTH SERVICES RESEARCH; HEALTH STATUS INDICATORS; HUMANS; INDIA; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS; QUESTIONNAIRES; SICKNESS IMPACT PROFILE;

EID: 84920818915     PISSN: 09286586     EISSN: 17445086     Source Type: Journal    
DOI: 10.3109/09286586.2014.885057     Document Type: Article

References (18)

1. Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-1053.
2. The Diabetic Retinopathy Study Research Group. Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. Ophthalmology 1981;88:583-600.
3. Early Treatment Diabetic Retinopathy Study Research Group. Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Ophthalmology 1991;98:766-785.
4. Brown MM, Brown GC, Sharma S, Shah G. Utility values and diabetic retinopathy. Am J Ophthalmol 1999;128:324-330.
5. Sharma S, Chen SJ, Lee FL, et al. Utilities associated with diabetic retinopathy: results from a Canadian sample. Br J Ophthalmol 2003;87:259-261.
6. Tung TH, Srinivasan G, Mei SS, et al. A community-based study for the utility values associated with diabetic retinopathy among type 2 diabetics in Kinmen, Taiwan. Diabetes Res Clin Pract 2005;68:265-273.
7. Gupta V, Brown GC, Sharma S, et al. Utility values among glaucoma patients: an impact on the quality of life. Br J Ophthalmol 2005;89:1241-1244.
8. Brown GC, Brown MM, Sharma S, et al. The reproducibility of ophthalmic utility values. Trans Am Ophthalmol Soc 2001;99:199-203; discussion 203-194.
9. Jampel HD. Glaucoma patients' assessment of their visual function and quality of life. Trans Am Ophthalmol Soc 2001;99:301-317.
10. Wilkinson CP, Ferris FL, Klein RE, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 2003;110:1677-1682.
11. Raman R, Rani PK, Reddi Rachepalle S, et al. Prevalence of diabetic retinopathy in India: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetics Study report 2. Ophthalmology 2009;116:311-318.
12. Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med 2001;33:337-343.
13. Dolan P. Modeling valuations for EuroQol health states. Med Care 1997;35:1095-1108.
14. Vyas S, Kumaranayake L. Constructing socio-economic status indices: how to use principal components analysis. Health Policy Plan 2006;21:459-468.
15. Lamping DL, et al. The community-acquired pneumonia symptom questionnaire: a new, patient-based outcome measure to evaluate symptoms in patients with community-acquired pneumonia. Chest 2002;122:920-929.
16. Sakthong P, Charoenvisuthiwongs R, Shabunthom R. A comparison of EQ-5D index scores using the UK, US, and Japan preference weights in a Thai sample with type 2 diabetes. Health Qual Life Outcomes 2008;6:71.
17. Kymes SM, Lee BS. Preference-based quality of life measures in people with visual impairment. Optom Vis Sci 2007;84:809-816.
18. Johnson JA, Luo N, Shaw JW, et al. Valuations of EQ-5D health states: are the United States and United Kingdom different? Med Care 2005;43:221-228.